Highlights and Quick Summary
- EBIT Margin for the quarter ending September 30, 2023 was -323.44% (a -67.26% decrease compared to previous quarter)
- Year-over-year quarterly EBIT Margin decreased by -76.0%
- Annual EBIT Margin for 2022 was -1550.55% (a 41.94% increase from previous year)
- Annual EBIT Margin for 2021 was -1092.42% (a 24.21% increase from previous year)
- Annual EBIT Margin for 2020 was -879.51% (a -4.01% decrease from previous year)
- Twelve month EBIT Margin ending September 30, 2023 was -847.42% (a 16.45% increase compared to previous quarter)
- Twelve month trailing EBIT Margin increased by 9.31% year-over-year
Trailing EBIT Margin for the last four month:
30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
---|---|---|---|
-847.42% | -727.69% | -773.41% | -775.28% |
Visit stockrow.com/ARAV
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBIT Margin of ARAVIVE, INC
Most recent EBIT Marginof ARAV including historical data for past 10 years.Interactive Chart of EBIT Margin of ARAVIVE, INC
ARAVIVE, INC EBIT Margin for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2023 | -323.44% | -987.91% | -1201.41% | – | – |
2022 | -1347.63% | -333.9% | -1202.91% | -1373.44% | -1550.55% |
2021 | -1386.4% | -479.85% | -195.59% | -3128.13% | -1092.42% |
2020 | -71.24% | 0.0% | 0.0% | 0.0% | -879.51% |
2019 | 0.0% | 0.0% | -126.85% | -337.79% | -916.22% |
2018 | 0.0% | 0.0% | 0.0% | 0.0% | -4799.27% |
2017 | 0.0% | 0.0% | 0.0% | 0.0% | -211.21% |
2016 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
2015 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
2014 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
2013 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
2012 | – | – | – | – | 0.0% |
Business Profile of ARAVIVE, INC
Sector: Healthcare
Industry: Biotechnology